TG THERAPEUTICS INC (TGTX) — institutional ownership
470 funds reported holding TG THERAPEUTICS INC in their latest 13F filings, worth $6.87B in total (CUSIP 88322Q108).
Largest holders
- BlackRock, Inc. (BLK) — $1.21B
- VANGUARD GROUP INC — $472M
- VANGUARD PORTFOLIO MANAGEMENT LLC — $438M
- STATE STREET CORP (STT, STT-PG) — $428M
- VANGUARD CAPITAL MANAGEMENT LLC — $338M
- GEODE CAPITAL MANAGEMENT, LLC — $200M
- D. E. Shaw & Co., Inc. — $191M
- Soleus Capital Management, L.P. — $161M
- PRICE T ROWE ASSOCIATES INC /MD/ — $152M
- Clearbridge Investments, LLC — $146M
Famous investors holding it
- D. E. Shaw portfolio (D. E. Shaw & Co.)
- Two Sigma portfolio (Two Sigma Investments)
- Ken Griffin portfolio (Citadel Advisors)
- Renaissance Technologies portfolio (Renaissance Technologies)
- Ray Dalio portfolio (Bridgewater Associates)
- Izzy Englander portfolio (Millennium Management)
Insider buying and selling at TG THERAPEUTICS INC
Who owns the most TGTX stock?
The largest institutional holders in the latest 13F filings are BlackRock, Inc. (BLK) ($1.21B), VANGUARD GROUP INC ($472M), VANGUARD PORTFOLIO MANAGEMENT LLC ($438M).
How many funds own TGTX?
470 funds reported holding it, worth $6.87B in total.